© All rights reserved. Powered by YOOtheme.

They Work Across the Class


Corticosteroids appear to be effective across the class, including dexamethasone, hydrocortisone and methylprednisolone. The largest trial to date, RECOVERY. examining dexamethasone, reported a huge effect in critically ill patients.

Tocilizumab is a 2nd efective drug

IL 6 Receptor Antagonists

The REMAP-CAP Investigators are soon to release the results of their interleukin 6 receptor antagonist domain, investigating tocilizumab and sarilumab in critically ill patients with COVID-19. We hope to bring you this results presentation at CCR

Beneficial in non-critically ill


The multi-platform ATTACC, ACTIV4-A, REMAP-CAP anticoagulation in COVID-19 results are soon to be announced, hopefully at a free live-streamed event hosted by Critical Care Reviews

Inneffective to date


Disappointingly, all anti-virals tested to date have proven ineffective across multiple trials, including remdesevir, hydroxychloroquine, and lopinovir-ritonavir

Antiviral Therapy





© All rights reserved.

Back to Top